Innocan Pharma Announces the Launch of Its Commercial Website

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – January 5, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan“), is pleased to announce the launch of its commercial web-platform, shop.innocanpharma.com. The Company, through its wholly owned subsidiary, Innocan Pharma Ltd. (“Innocan Israel”), has signed certain agreements with world leading companies for the fulfillment, logistics, and service of the website. The new website has been designed to offer a user-friendly experience with excellent navigation and functionality, allowing consumers to see the full product information to enhance the shopping experience.

The online product distribution will be led and handled by Brandzon Co Ltd. (www.brandzon.co), a company which specializes in ecommerce growth and worldwide acceleration. The Brandzon team has a proven sales track record worldwide, with global 3PL (Third-Party-Logistics) capabilities.

Roni Kamhi, CEO & Co-founder of Brandzon said, “We believe that Innocan is a leading innovative pharmaceutical company that has the potential to bring an advanced formulated product into the skincare market with the science to back it. Together we can achieve success in the ecommerce space and generate revenue for both companies.”

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/71307

Powered by WPeMatico

Newsfile is a customer-focused newswire team that delivers press releases and corporate announcements to the global financial community. Approved by all stock exchanges, Newsfile offers broad access to media, analysts, investors and market participants. With agile services, proactive customer care and affordable pricing; Newsfile makes it easy for companies to tell their story to the audiences they need to reach.